| Name | Title | Contact Details |
|---|
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.
At CareFusion, we are united in our vision to improve the safety and lower the cost of healthcare for generations to come. Our 16,650 worldwide employees are passionate about healthcare and helping those that deliver it - from the hospital pharmacy to the intensive care unit, the operating theatre to the patient bedside and beyond. Our proven product families include Intermed, AVEA, VELA, SensorMedics, AirLife and respiratory products, Pyxis automated dispensing and patient identification systems, V. Mueller and Snowden-Pencer surgical instruments, Achieve Temno and Jamshidi, and the PleurX drainage system and the Alaris IV pumps (not sold in Brazil). To make global healthcare better, we partner with our customers to provide clinically differentiated respiratory solutions to help optimize patient care, improve medication management and lower the cost in procedural areas.
NoIR Laser Company is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
InfiMed, Inc. is a Liverpool, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.